597 related articles for article (PubMed ID: 23832012)
21. SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.
Piazza R; Magistroni V; Redaelli S; Mauri M; Massimino L; Sessa A; Peronaci M; Lalowski M; Soliymani R; Mezzatesta C; Pirola A; Banfi F; Rubio A; Rea D; Stagno F; Usala E; Martino B; Campiotti L; Merli M; Passamonti F; Onida F; Morotti A; Pavesi F; Bregni M; Broccoli V; Baumann M; Gambacorti-Passerini C
Nat Commun; 2018 Jun; 9(1):2192. PubMed ID: 29875417
[TBL] [Abstract][Full Text] [Related]
22. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.
Stieglitz E; Troup CB; Gelston LC; Haliburton J; Chow ED; Yu KB; Akutagawa J; Taylor-Weiner AN; Liu YL; Wang YD; Beckman K; Emanuel PD; Braun BS; Abate A; Gerbing RB; Alonzo TA; Loh ML
Blood; 2015 Jan; 125(3):516-24. PubMed ID: 25395418
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
Ouyang Y; Qiao C; Chen Y; Zhang SJ
Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
Jankowska AM; Szpurka H; Tiu RV; Makishima H; Afable M; Huh J; O'Keefe CL; Ganetzky R; McDevitt MA; Maciejewski JP
Blood; 2009 Jun; 113(25):6403-10. PubMed ID: 19372255
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
Wang L; Du F; Zhang HM; Wang HX
Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341
[TBL] [Abstract][Full Text] [Related]
26. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia.
Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ
J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115
[TBL] [Abstract][Full Text] [Related]
27. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
[TBL] [Abstract][Full Text] [Related]
28. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
[TBL] [Abstract][Full Text] [Related]
29. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
[TBL] [Abstract][Full Text] [Related]
30. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.
Faisal M; Stark H; Büsche G; Schlue J; Teiken K; Kreipe HH; Lehmann U; Bartels S
Cancer Med; 2019 Feb; 8(2):742-750. PubMed ID: 30635983
[TBL] [Abstract][Full Text] [Related]
32. Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
Patnaik MM; Lasho TL
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):450-459. PubMed ID: 33275756
[TBL] [Abstract][Full Text] [Related]
33. Current and evolving understanding of atypical chronic myeloid leukemia.
Schwartz LC; Mascarenhas J
Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis.
Wang H; Gao Y; Qin L; Zhang M; Shi W; Feng Z; Guo L; Zhu B; Liao S
Orphanet J Rare Dis; 2023 May; 18(1):107. PubMed ID: 37150818
[TBL] [Abstract][Full Text] [Related]
35. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome.
Hoischen A; van Bon BW; Gilissen C; Arts P; van Lier B; Steehouwer M; de Vries P; de Reuver R; Wieskamp N; Mortier G; Devriendt K; Amorim MZ; Revencu N; Kidd A; Barbosa M; Turner A; Smith J; Oley C; Henderson A; Hayes IM; Thompson EM; Brunner HG; de Vries BB; Veltman JA
Nat Genet; 2010 Jun; 42(6):483-5. PubMed ID: 20436468
[TBL] [Abstract][Full Text] [Related]
36. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Gambacorti-Passerini CB; Donadoni C; Parmiani A; Pirola A; Redaelli S; Signore G; Piazza V; Malcovati L; Fontana D; Spinelli R; Magistroni V; Gaipa G; Peronaci M; Morotti A; Panuzzo C; Saglio G; Usala E; Kim DW; Rea D; Zervakis K; Viniou N; Symeonidis A; Becker H; Boultwood J; Campiotti L; Carrabba M; Elli E; Bignell GR; Papaemmanuil E; Campbell PJ; Cazzola M; Piazza R
Blood; 2015 Jan; 125(3):499-503. PubMed ID: 25343957
[TBL] [Abstract][Full Text] [Related]
37. The recurrent SETBP1 c.2608G > A, p.(Gly870Ser) variant in a patient with Schinzel-Giedion syndrome: an illustrative case of the utility of whole exome sequencing in a critically ill neonate.
Leone MP; Palumbo P; Palumbo O; Di Muro E; Chetta M; Laforgia N; Resta N; Stella A; Castellana S; Mazza T; Castori M; Carella M; Bukvic N
Ital J Pediatr; 2020 May; 46(1):74. PubMed ID: 32460883
[TBL] [Abstract][Full Text] [Related]
38. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
39. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
Damm F; Itzykson R; Kosmider O; Droin N; Renneville A; Chesnais V; Gelsi-Boyer V; de Botton S; Vey N; Preudhomme C; Clavert A; Delabesse E; Park S; Birnbaum D; Fontenay M; Bernard OA; Solary E
Leukemia; 2013 Jun; 27(6):1401-3. PubMed ID: 23443343
[No Abstract] [Full Text] [Related]
40. Myb expression is critical for myeloid leukemia development induced by Setbp1 activation.
Nguyen N; Vishwakarma BA; Oakley K; Han Y; Przychodzen B; Maciejewski JP; Du Y
Oncotarget; 2016 Dec; 7(52):86300-86312. PubMed ID: 27863435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]